<DOC>
	<DOCNO>NCT00603785</DOCNO>
	<brief_summary>We propose study effect Xolair patient chronic sinusitis without nasal polyp . Because similarity inflammatory process find asthmas rhinitis find chronic sinusitis , hypothesize sinusitis respond Xolair , asthma .</brief_summary>
	<brief_title>Effects Anti-IgE Antibody Omalizumab Patients With Chronic Sinusitis</brief_title>
	<detailed_description>We propose study effect Xolair patient chronic sinusitis without nasal polyp . Since Xolair show effective asthmatic subject evidence atopy elevate IgE , limit study patient chronic sinusitis parameter . The primary objective determine Xolair decrease mucosal thickness CT scan 6 month treatment .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>Males females 18 75 year age Chronic sinusitis define symptom great 12 week despite treatment . Paranasal sinus CT scan show evidence chronic sinusitis . Positive skin RAST test inhalant allergen . Serum total IgE 30 700 International Units/ml . Body weight less 150kg . Impaired quality life measure Rhinosinusitis Disability Index ( RSDI ) . Women childbearing potential use contraception method ( ) ( Birth control pill , depo Provera , double barrier ) well woman breastfeed . Known sensitivity Xolair Patients severe medical condition view investigator prohibits participation study ( heart , lung , kidney , neurological , oncologic liver disease ) . Use investigational agent last 30 day . No measurable disability RSDI . Immunocompromised patient patient ciliary disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Chronic sinusitis</keyword>
	<keyword>Xolair</keyword>
	<keyword>Nasal Discharge</keyword>
	<keyword>Nasal Obstruction</keyword>
	<keyword>Facial Pain</keyword>
	<keyword>Hyposmia</keyword>
</DOC>